ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
4,325
Screening encounters
5,601
Diagnostic referrals
1,060
Outstanding pathways
335

Screening pathway

  1. Screening5,601Encounters
  2. Positive finding1,983Documented findings
  3. Referral1,060Diagnostic referrals
  4. Follow-up1,284Diagnostic visits
  5. Outcome725Resolved pathways

Stage totals use different units. Pending pathways: 285. Insufficient observation: 50.

Participant insight

Expanded synthetic participant 2437 · EXP-2437Synthetic · Site C

Full participant history through 2027-10-08, across modalities and pathways.

  1. · Screening · VIA · Initial · Programme entry
  2. · Screening result · VIA · VIA positive · Adequate
  3. · Repeat plan · HPV DNA · Prior VIA positive · Scheduled for 2026-07-14
  4. · Diagnostic referral · EXP-2437-T-R
  5. · Contact attempt · Reached
  6. · Diagnostic booking · Initial booking
  7. · Barrier documented · Transport difficulty
  8. · Diagnostic visit · Missed
  9. · Diagnostic booking · Rebooking
  10. · Diagnostic visit · Missed
  11. · Screening · HPV DNA · Repeat · Prior VIA positive
  12. · Screening result · HPV DNA · HPV not detected · Adequate

Referral-time risk

Pathway status at observation · Pending

Loading prediction…

Observed day-60 outcome · Unresolved

Screened participants

4325 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-2766 · Expanded synthetic participant 2766Site B — Peri-Urban Access Programme
EXP-2767 · Expanded synthetic participant 2767Site B — Peri-Urban Access Programme
EXP-2768 · Expanded synthetic participant 2768Site D — Community Engagement Programme
EXP-2769 · Expanded synthetic participant 2769Site A — Urban Referral Hub
EXP-2770 · Expanded synthetic participant 2770Site C — Rural Outreach Programme
EXP-2771 · Expanded synthetic participant 2771Site B — Peri-Urban Access Programme
EXP-2772 · Expanded synthetic participant 2772Site E — Resource-Constrained Navigation Programme
EXP-2773 · Expanded synthetic participant 2773Site E — Resource-Constrained Navigation Programme
EXP-2774 · Expanded synthetic participant 2774Site D — Community Engagement Programme
EXP-2775 · Expanded synthetic participant 2775Site B — Peri-Urban Access Programme
EXP-2776 · Expanded synthetic participant 2776Site E — Resource-Constrained Navigation Programme
EXP-2777 · Expanded synthetic participant 2777Site A — Urban Referral Hub
EXP-2778 · Expanded synthetic participant 2778Site D — Community Engagement Programme
EXP-2780 · Expanded synthetic participant 2780Site D — Community Engagement Programme
EXP-2781 · Expanded synthetic participant 2781Site C — Rural Outreach Programme
EXP-2782 · Expanded synthetic participant 2782Site C — Rural Outreach Programme
EXP-2783 · Expanded synthetic participant 2783Site C — Rural Outreach Programme
EXP-2784 · Expanded synthetic participant 2784Site D — Community Engagement Programme
EXP-2785 · Expanded synthetic participant 2785Site C — Rural Outreach Programme
EXP-2786 · Expanded synthetic participant 2786Site C — Rural Outreach Programme
EXP-2787 · Expanded synthetic participant 2787Site B — Peri-Urban Access Programme
EXP-2789 · Expanded synthetic participant 2789Site A — Urban Referral Hub
EXP-2790 · Expanded synthetic participant 2790Site A — Urban Referral Hub
EXP-2791 · Expanded synthetic participant 2791Site D — Community Engagement Programme
EXP-2792 · Expanded synthetic participant 2792Site A — Urban Referral Hub

Programme insights

Encounters by modality

VIA
1970
HPV DNA
2904
Cytology
727

Navigation activity

Barrier documented
937
Contact attempt
1505
Navigation intervention
417
Diagnostic booking
1301
Diagnostic visit
1284

Documented barriers

Contact difficulty
298
Transport difficulty
311
Appointment coordination
328

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.